ABBV-744 |
Catalog No.GC19409 |
ABBV-744는 BRD2, BRD3, BRD4 및 BRDT에 대해 IC50 값이 4~18nM인 BET 계열 단백질의 BDII 도메인에 대한 동급 최초의 경구 활성 및 선택적 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2138861-99-9
Sample solution is provided at 25 µL, 10mM.
ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer.
Reference
[1]. FIDANZE, Steven D., et al. BROMODOMAIN INHIBITORS. WO 2017177955 A1.
Review for ABBV-744
Average Rating: 5
(Based on Reviews and 15 reference(s) in Google Scholar.)Review for ABBV-744
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *